Marzena Wełnicka-Jaśkiewicz
- Cancer Research top 5%
- Breast Cancer Treatment Studies 12
- Cancer Genomics and Diagnostics 4
- Oncology top 5%
- Cancer Cells and Metastasis 11
- HER2/EGFR in Cancer Research 10
- Cancer Treatment and Pharmacology 7
- Cancer Diagnosis and Treatment 5
- Peptidase Inhibition and Analysis 5
- Physiology top 5%
-
- Estrogen and related hormone effects 5
- Co-authors
- Anna J. ŻaczekJarosław SkokowskiAleksandra MarkiewiczBarbara SeroczyńskaJolanta SzadeJacek JassemTanja ČuferL. Mauriac
- Cited by
- Cancer ResearchOncologyPhysiology
- Partner nations
- PolandBelgiumNetherlands
In The Last Decade
Marzena Wełnicka-Jaśkiewicz
42 papers receiving 805 citations
Peers
Comparison fields: 5 of 71
- Cancer Research 354
- Oncology 610
- Physiology 54
- Pathology and Forensic Medicine 85
- Pulmonary and Respiratory Medicine 154
Countries citing papers authored by Marzena Wełnicka-Jaśkiewicz
This map shows the geographic impact of Marzena Wełnicka-Jaśkiewicz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marzena Wełnicka-Jaśkiewicz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marzena Wełnicka-Jaśkiewicz more than expected).
Fields of papers citing papers by Marzena Wełnicka-Jaśkiewicz
This network shows the impact of papers produced by Marzena Wełnicka-Jaśkiewicz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marzena Wełnicka-Jaśkiewicz. The network helps show where Marzena Wełnicka-Jaśkiewicz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Marzena Wełnicka-Jaśkiewicz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 1 | |
| 2 | 2018 | 18 | |
| 3 | 2017 | 2 | |
| 4 | 2017 | 1 | |
| 5 | 2015 | 4 | |
| 6 | 2014 | 38 | |
| 7 | 2013 | 1 | |
| 8 | 2013 | 22 | |
| 9 | 2011 | 72 | |
| 10 | 2010 | 11 | |
| 11 | 2010 | 17 | |
| 12 | 2007 | 20 | |
| 13 | 2006 | 1 | |
| 14 | 2006 | 15 | |
| 15 | 2005 | 44 | |
| 16 | 2004 | 8 | |
| 17 | The role of chemotherapy in soft tissue sarcomas | 2003 | 1 |
| 18 | Mediastinal malignant germ cell tumours: presentation of 15 cases and literature review | 2003 | 3 |
| 19 | 2003 | 153 | |
| 20 | The occurrence of cerebellar hemangioblastoma in numerous first degree relatives with von Hippel-Lindau disease. | 1999 | 4 |
About Marzena Wełnicka-Jaśkiewicz
Marzena Wełnicka-Jaśkiewicz is a scholar working on Oncology, Cancer Research and Physiology, having authored 42 papers that have together received 820 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (12 papers), Cancer Cells and Metastasis (11 papers), HER2/EGFR in Cancer Research (10 papers), Cancer Treatment and Pharmacology (7 papers), Cancer Diagnosis and Treatment (5 papers), Estrogen and related hormone effects (5 papers), Peptidase Inhibition and Analysis (5 papers) and Cancer Genomics and Diagnostics (4 papers). The work is most often cited by research in Cancer Research (354 citations), Oncology (610 citations) and Physiology (54 citations). Marzena Wełnicka-Jaśkiewicz has collaborated with scholars based in Poland, Belgium and Netherlands. Frequent co-authors include Anna J. Żaczek, Jarosław Skokowski, Aleksandra Markiewicz, Barbara Seroczyńska, Jolanta Szade, Jacek Jassem, Tanja Čufer, L. Mauriac, Janusz Jaśkiewicz and Hervé Bonnefoi. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.